We applied the MAGEC3 protein level predictor to an independent set of cases sequenced and processed for TCGA’s pan-cancer analysis (n = 282 ovarian cancer patients), which did not have measured MAGEC3 protein levels. This evidence concerns the gene MAGEC3 and cancer.